Business
VMS Rehab Systems, Inc. Eyes Anomaly in Stock Price
VMS Rehab Systems, Inc. Eyes Anomaly in Stock Price.
About this update from Vms Rehab Systems
[{"type":"text","content":"\n\n\n\nVMS Rehab Systems, Inc. Eyes Anomaly in Stock Price\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nVMS Rehab Systems, Inc. Eyes Anomaly in Stock Price\nPR Newswire\nOTTAWA, Ontario, June 27, 2016\n\n\n\nOTTAWA, Ontario, June 27, 2016 /PRNewswire/ -- VMS Rehab Systems, Inc. (www.vmsrehabsystemsinc.com) reported today that the Company's Board will take whatever measures required to build a strong and stable market for trading in the Company's stock which is currently listed on the OTC Markets-pink current trading platform.\n\nExplains Michael S Wexler, Company Chairman and CEO, \"We are seeing an anomaly in market trading activities that may well be difficult to understand, not only by the Company, but shareholders and market players as well. I want to assure all of our stakeholders and market participants that the fundamentals of our company in terms of corporate initiatives reported earlier in the year for VMS and its generic drug unit BioPharmcor BV (www.Biopharmcor.com) are not only intact but serve as guidance for the Company's growth and development activities today and tomorrow. Most importantly, we are aggressively pursuing a number of funding initiatives within our drug unit to ensure that BioPharmcor meets our timeline for completing human trials on its tadalafil development program prior to the end of 2016. We anticipate that additional new generic drug programs to build out BioPharmcor's drug pipeline will be reported within 60-90 days.\"\n\nVMS' drug unit BioPharmcor BV is currently developing a generic tadalafil drug product which is recognized as a first line treatment for men suffering from Erectile Deficiency (ED) and Benign Prostatic Hyperplasia (BPH). \n\nEstablished in 1998, VMS Rehab Systems, Inc. is headquartered in Ottawa, Canada and maintains affiliate offices in Amsterdam, The Netherlands and Warsaw, Poland. The shares of VMS Rehab Systems, Inc. are listed on the US OTC Pink Current Market (Symbol: VRSYF)\n\nFORWARD-LOOKING INFORMATION \n\nCertain statements contained in this press release constitute forward-looking information. ...